1- Carlson CJ, Albery GF, Merow C, Trisos CH, Zipfel CM, Eskew EA, et al. Climate change increases cross-species viral transmission risk. Nature. 2022;607(7919):555-62.
2- Woolhouse MEJ, Brierley L. Epidemiological characteristics of human-infective RNA viruses. Sci Data. 2018;5:180017.
3- Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33.
4- Lam TT, Jia N, Zhang YW, Shum MH, Jiang JF, Zhu HC, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583(7815):282-5.
5- Baize S, Pannetier D, Oestereich L, Rieger T, Koivogui L, Magassouba N, et al. Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med. 2014;371(15):1418-25.
6- Faria NR, Azevedo R, Kraemer MUG, Souza R, Cunha MS, Hill SC, et al. Zika virus in the Americas: Early epidemiological and genetic findings. Science. 2016;352(6283):345-9.
7- Chua KB, Bellini WJ, Rota PA, Harcourt BH, Tamin A, Lam SK, et al. Nipah virus: A recently emergent deadly paramyxovirus. Science. 2000;288(5470):1432-5.
8- Beigel J, Farrar J, Han A, Hayden F, Hyer R, De Jong M, et al. Avian influenza A (H5N1) infection in humans. N Engl J Med. 2005;353(13):1374-85.
9- Hassell JM, Begon M, Ward MJ, Fèvre EM. Urbanization and disease emergence: Dynamics at the wildlife-livestock-human interface. Trends Ecol Evol. 2017;32(1):55-67.
10- Gottdenker NL, Streicker DG, Faust CL, Carroll CR. Anthropogenic land use change and infectious diseases: A review of the evidence. Ecohealth. 2014;11(4):619-32.
11- Heymann DL, Chen L, Takemi K, Fidler DP, Tappero JW, Thomas MJ, et al. Global health security: The wider lessons from the west African Ebola virus disease epidemic. Lancet. 2015;385(9980):1884-901.
12- Smolinski MS, Hamburg MA, Lederberg J, editors. Microbial threats to health: Emergence, detection, and response. Washington D.C.: National Academies Press; 2003.
13- Duffy S. Why are RNA virus mutation rates so damn high?. PLoS Biol. 2018;16(8):e3000003.
14- Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, et al. Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies. Nature. 2022;602(7898):657-63.
15- Lloyd-Smith JO. Vacated niches, competitive release and the community ecology of pathogen eradication. Philos Trans R Soc Lond B Biol Sci. 2013;368(1623):20120150.
16- Rocklöv J, Dubrow R. Climate change: An enduring challenge for vector-borne disease prevention and control. Nat Immunol. 2020;21(5):479-83.
17- Ryan SJ, Carlson CJ, Mordecai EA, Johnson LR. Global expansion and redistribution of Aedes-borne virus transmission risk with climate change. PLoS Negl Trop Dis. 2019;13(3):e0007213.
18- Bloomfield LS, McIntosh TL, Lambin EF. Habitat fragmentation, livelihood behaviors, and contact between people and nonhuman primates in Africa. Landsc Ecol. 2020;35(4):985-1000.
19- Kissler SM, Tedijanto C, Goldstein E, Grad YH, Lipsitch M. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period. Science. 2020;368(6493):860-8.
20- Anyamba A, Chretien JP, Small J, Tucker CJ, Formenty PB, Richardson JH, et al. Prediction of a Rift Valley fever outbreak. Proc Natl Acad Sci U S A. 2009;106(3):955-9.
21- Tatem AJ, Rogers DJ, Hay SI. Global transport networks and infectious disease spread. Adv Parasitol. 2006;62:293-343.
22- WHO. WHO guidelines for the global surveillance of severe acute respiratory syndrome (SARS): Updated recommendations, October 2004. Geneva: World Health Organization; 2004.
23- Relman DA. The increasingly compelling moral responsibilities of life scientists. Hastings Cent Rep. 2013;43(2):34-5.
24- Casadevall A, Imperiale MJ. Risks and benefits of gain-of-function experiments with pathogens of pandemic potential, such as influenza virus: A call for a science-based discussion. mBio. 2014;5(4):e01730-14.
25- Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, et al. Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife. 2020;9:e61312.
26- Moon S, Sridhar D, Pate MA, Jha AK, Clinton C, Delaunay S, et al. Will Ebola change the game? Ten essential reforms before the next pandemic. The report of the Harvard-LSHTM Independent Panel on the Global Response to Ebola. Lancet. 2015;386(10009):2204-21.
27- Farmer P. Infections and inequalities: The modern plagues. Berkeley: University of California Press; 2001.
28- Abrams EM, Szefler SJ. COVID-19 and the impact of social determinants of health. Lancet Respir Med. 2020;8(7):659-61.
29- Gayer M, Legros D, Formenty P, Connolly MA. Conflict and emerging infectious diseases. Emerg Infect Dis. 2007;13(11):1625-31.
30- Federspiel F, Ali M. The cholera outbreak in Yemen: Lessons learned and way forward. BMC Public Health. 2018;18(1):1338.
31- Gostin LO, Katz R. The international health regulations: The governing framework for global health security. Milbank Q. 2016;94(2):264-313.
32- Gostin LO, Friedman EA, Hossain S, Mukherjee J, Zia-Zarifi S, Clinton C, et al. Human rights and the COVID-19 pandemic: A retrospective and prospective analysis. Lancet. 2023;401(10371):154-68.
33- Atlas RM. Bioterriorism: From threat to reality. Annu Rev Microbiol. 2002;56:167-85.
34- Jernigan JA, Stephens DS, Ashford DA, Omenaca C, Topiel MS, Galbraith M, et al. Bioterrorism-related inhalational anthrax: The first 10 cases reported in the United States. Emerg Infect Dis. 2001;7(6):933-44.
35- Bloom DE, Cadarette D. Infectious disease threats in the twenty-first century: Strengthening the global response. Front Immunol. 2019;10:549.
36- Pollard AJ, Bijker EM. A guide to vaccinology: From basic principles to new developments. Nat Rev Immunol. 2021;21(2):83-100.
37- Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383(27):2603-15.
38- Pawar B, Loganathan S, Mukkatira Belliappa K, Ranganathan LB, Thekdi KP, Hiware SD. A comprehensive review of vaccine development: From traditional platforms to messenger RNA (mRNA) technologies. Cureus. 2026;18(1):e100608.
39- Taylor PC, Adams AC, Hufford MM, De La Torre I, Winthrop K, Gottlieb RL. Neutralizing monoclonal antibodies for treatment of COVID-19. Nat Rev Immunol. 2021;21(6):382-93.
40- Weinreich DM, Sivapalasingam S, Norton T, Ali S, Gao H, Bhore R, et al. REGN-COV2, a neutralizing antibody cocktail, in outpatients with Covid-19. N Engl J Med. 2021;384(3):238-51.
41- Mulangu S, Dodd LE, Davey RT Jr, Tshiani Mbaya O, Proschan M, Mukadi D, et al. A randomized, controlled trial of ebola virus disease therapeutics. N Engl J Med. 2019;381(24):2293-303.
42- Planas D, Saunders N, Maes P, Guivel-Benhassine F, Planchais C, Buchrieser J, et al. Considerable escape of SARS-CoV-2 Omicron to antibody neutralization. Nature. 2022;602(7898):671-5.
43- De Clercq E, Li G. Approved antiviral drugs over the past 50 years. Clin Microbiol Rev. 2016;29(3):695-747.
44- Hammond J, Leister-Tebbe H, Gardner A, Abreu P, Bao W, Wisemandle W, et al. Oral nirmatrelvir for high-risk, nonhospitalized adults with Covid-19. N Engl J Med. 2022;386(15):1397-408.
45- Colman PM. Influenza virus neuraminidase: Structure, antibodies, and inhibitors. Protein Sci. 1994;3(10):1687-96.
46- Cohen AA, Gnanapragasam PNP, Lee YE, Hoffman PR, Ou S, Kakutani LM, et al. Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice. Science. 2021;371(6530):735-41.
47- Bloom K, Van Den Berg F, Arbuthnot P. Self-amplifying RNA vaccines for infectious diseases. Gene Ther. 2021;28(3-4):117-29.
48- Kaufmann SHE, Dorhoi A, Hotchkiss RS, Bartenschlager R. Host-directed therapies for bacterial and viral infections. Nat Rev Drug Discov. 2018;17(1):35-56.
49- Kalil AC, Patterson TF, Mehta AK, Tomashek KM, Wolfe CR, Ghazaryan V, et al. Baricitinib plus remdesivir for hospitalized adults with Covid-19. N Engl J Med. 2021;384(9):795-807.
50- Zumla A, Chan JF, Azhar EI, Hui DS, Yuen KY. Coronaviruses-drug discovery and therapeutic options. Nat Rev Drug Discov. 2016;15(5):327-47.
51- Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020;12(541):eabb5883.
52- Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, et al. Therapeutic siRNA: State of the art. Signal Transduct Target Ther. 2020;5(1):101.
53- Mancuso P, Chen C, Kaminski R, Gordon J, Liao S, Robinson JA, et al. CRISPR based editing of SIV proviral DNA in ART treated non-human primates. Nat Commun. 2020;11(1):6065.
54- Wouters OJ, Shadlen KC, Salcher-Konrad M, Pollard AJ, Larson HJ, Teerawattananon Y, et al. Challenges in ensuring global access to COVID-19 vaccines: Production, affordability, allocation, and deployment. Lancet. 2021;397(10278):1023-34.
55- Graham BS, Sullivan NJ. Emerging viral diseases from a vaccinology perspective: Preparing for the next pandemic. Nat Immunol. 2018;19(1):20-8.
56- Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, Casas N, et al. One health: A new definition for a sustainable and healthy future. PLoS Pathog. 2022;18(6):e1010537.
57- Hayman DTS, Adisasmito WB, Almuhairi S, Behravesh CB, Bilivogui P, Bukachi SA, et al. Developing one health surveillance systems. One Health. 2023;17:100617.
58- Dobson AP, Pimm SL, Hannah L, Kaufman L, Ahumada JA, Ando AW, et al. Ecology and economics for pandemic prevention. Science. 2020;369(6502):379-81.
59- Chowell G, Nishiura H. Transmission dynamics and control of Ebola virus disease (EVD): A review. BMC Med. 2014;12:196.
60- Bui C, Bethmont A, Chughtai AA, Gardner L, Sarkar S, Hassan S, et al. A systematic review of the comparative epidemiology of avian and human influenza A H5N1 and H7N9 - Lessons and unanswered questions. Transbound Emerg Dis. 2016;63(6):602-20.
61- Ciota AT, Kramer LD. Vector-virus interactions and transmission dynamics of West Nile virus. Viruses. 2013;5(12):3021-47.
62- Gutiérrez-Bugallo G, Piedra LA, Rodriguez M, Bisset JA, Lourenço-de-Oliveira R, Weaver SC, et al. Vector-borne transmission and evolution of Zika virus. Nat Ecol Evol. 2019;3(4):561-9.
63- Gurley ES, Hegde ST, Hossain K, Sazzad HMS, Hossain MJ, Rahman M, et al. Convergence of humans, bats, trees, and culture in nipah virus transmission, Bangladesh. Emerg Infect Dis. 2017;23(9):1446-53.
64- Mackenzie JS, Jeggo M. The one health approach-why is it so important?. Trop Med Infect Dis. 2019;4(2):88.
65- Jesudason T. Operational addendum for One Health Joint Plan of Action. Lancet Infect Dis. 2024;24(3):e158.
66- Bonilla-Aldana DK, Holguin-Rivera Y, Perez-Vargas S, Trejos-Mendoza AE, Balbin-Ramon GJ, Dhama K, et al. Importance of the one Health approach to study the SARS-CoV-2 in Latin America. One Health. 2020;10:100147.
67- Destoumieux-Garzón D, Mavingui P, Boetsch G, Boissier J, Darriet F, Duboz P, et al. The One Health concept: 10 years old and a long road ahead. Front Vet Sci. 2018;5:14.
68- The Lancet. COVID-19: A new lens for non-communicable diseases. Lancet. 2020;396(10252):649.
69- Gostin LO, Habibi R, Meier BM. Has global health law risen to meet the COVID-19 challenge? Revisiting the international health regulations to prepare for future threats. J Law Med Ethics. 2020;48(2):376-81.
70- Allen T, Murray KA, Zambrana-Torrelio C, Morse SS, Rondinini C, Di Marco M, et al. Global hotspots and correlates of emerging zoonotic diseases. Nat Commun. 2017;8(1):1124.
71- Morse SS, Mazet JA, Woolhouse M, Parrish CR, Carroll D, Karesh WB, et al. Prediction and prevention of the next pandemic zoonosis. Lancet. 2012;380(9857):1956-65.
72- Haldane V, De Foo C, Abdalla SM, Jung AS, Tan M, Wu S, et al. Health systems resilience in managing the COVID-19 pandemic: Lessons from 28 countries. Nat Med. 2021;27(6):964-80.
73- Kickbusch I, Reddy KS. Global health governance - the next political revolution. Public Health. 2015;129(7):838-42.
74- Eaneff S, Boyce MR, Graeden E, Lowrance D, Moore M, Katz R. Financing global health security: Estimating the costs of pandemic preparedness in Global Fund eligible countries. BMJ Glob Health. 2023;8(1):e008960.
75- Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601-15.
76- Graham EL, Clark JR, Orban ZS, Lim PH, Szymanski AL, Taylor C, et al. Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 "long haulers". Ann Clin Transl Neurol. 2021;8(5):1073-85.
77- Loomba S, De Figueiredo A, Piatek SJ, De Graaf K, Larson HJ. Measuring the impact of COVID-19 vaccine misinformation on vaccination intent in the UK and USA. Nat Hum Behav. 2021;5(3):337-48.
78- Tangcharoensathien V, Calleja N, Nguyen T, Purnat T, D'Agostino M, Garcia-Saiso S, et al. Framework for managing the COVID-19 infodemic: Methods and results of an online, crowdsourced WHO technical consultation. J Med Internet Res. 2020;22(6):e19659.
79- Afrough B, Dowall S, Hewson R. Emerging viruses and current strategies for vaccine intervention. Clin Exp Immunol. 2019;196(2):157-66.
80- Trovato M, Sartorius R, D'Apice L, Manco R, De Berardinis P. Viral emerging diseases: Challenges in developing vaccination strategies. Front Immunol. 2020;11:2130.
81- Yu X, He Q, Kong Q. Multidisciplinary approaches to combat emerging viruses: Diagnostics, therapeutic gene and vaccine delivery, and nanotherapeutics. Front Microbiol. 2024;15:1387623.
82- Aw DZH, Zhang DX, Vignuzzi M. Strategies and efforts in circumventing the emergence of antiviral resistance against conventional antivirals. NPJ Antimicrob Resist. 2025;3(1):54.
83- Alizon S. Predicting the virulence of future emerging zoonotic viruses. PLoS Biol. 2023;21(9):e3002286.
84- Holmes EC. What can we predict about viral evolution and emergence?. Curr Opin Virol. 2013;3(2):180-4.
85- Hunter PR. Future disease burden due to the rise of emerging infectious disease secondary to climate change may be being under-estimated. Virulence. 2025;16(1):2501243.
86- Liao H, Lyon CJ, Ying B, Hu T. Climate change, its impact on emerging infectious diseases and new technologies to combat the challenge. Emerg Microbes Infect. 2024;13(1):2356143.
87- He Y, Liu WJ, Jia N, Richardson S, Huang C. Viral respiratory infections in a rapidly changing climate: The need to prepare for the next pandemic. EBioMedicine. 2023;93:104593.
